CNB Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Fortress Biotech Inc

Watchlist Manager

Watchlist

Price: 4.131 EUR Market Closed

Market Cap: €554.9m

F	Fortress Biotech Inc F:CNB	US
	HSBC Holdings PLC LSE:HSBA	UK
G	Greencoat Renewables PLC LSE:GRP	IE
	SMCP SA LSE:0RVA	FR
C	Chorus Ltd F:7CH	NZ
S	Shiseido Co Ltd DUS:SHD	JP
C	CK Power PCL SET:CKP	TH
C	Carlisle Companies Inc SWB:CLE	US
S	Suzuki Motor Corp F:SUK	JP
	Airtel Africa PLC F:9AA0	UK

Profitability Summary

Fortress Biotech Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

67%

Strong 3Y Average Gross Margin

65%

Gross Margin is Increasing

55% > 67%

Negative Operating Margin

-111%

Negative 3Y Average Operating Margin

-185%

Operating Margin is Increasing

-335% > -111%

Negative Net Margin

-3%

Negative 3Y Average Net Margin

-80%

Net Margin is Increasing

-153% > -3%

Negative Free Cash Flow Margin

-104%

Negative 3Y Average Free Cash Flow Margin

-162%

Free Cash Flow Margin is Increasing

-276% > -104%

Negative ROE

-5%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-429%

ROIC is Increasing

-553% > -112%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.